SC 13G
SUTRO BIOPHARMA, INC.
- Company
- SUTRO BIOPHARMA, INC.
- Filed
- October 10, 2023
- Accession Number
- 0000902664-23-005066
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →